Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Glossary

Hot vs Cold: the differences between tumor types

Using Biomarkers to Detect Cancer

Cutaneous Manifestations of Internal Malignancy

What is Cancer of Unknown Primary?

Secondary Lung Cancer

Secondary Brain Cancer

Why are Cancer Cell Lines Useful?

Cancer Screening Considerations: Balancing the Benefits and Risks

Metastatic Migration in Cancer may be Influenced by Metabolism

The Cancer Cell Surface Proteome as a Therapeutic Target

See more featured articles »

Investigating the Molecular Mechanisms of Cancer

Exploiting Enzymes in Cancer Diagnosis and Therapy

Overview of Cell Viability and Cytotoxicity

Cancer Pathophysiology

What Causes Cancer?

Extracellular Vesicles as Floating Cancer Biomarkers

What is Tumorigenesis?

Insight into Cancer Vaccines

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Pain

What is Cancer?

Microfluidic cancer treatment screen combined with flow cytometry

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Cancer Management

Insights into Oncofertility

Effects of Social and Economic Deprivation on Cancer Mortality

Cancer Classification

Transforming Cancer Care through Genomic Testing

Caring for a Loved One with Cancer

The Effects of Cancer on Family Life

What is Immunochemotherapy?

Cancer Pain Management

Cancer Diagnosis

What is the Tumor Microenvironment?

Hypoxia Markers and Their Importance

Cancer Symptoms

Cancer History

Living with Cancer Pain

The Biochemistry of Breast Cancer Screening

Assay for Monitoring and Treating Malignant Brain Tumors

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Cancer Prevention: Lowering your Risk

Cancer Epidemiology

Is Cancer a Metabolic Disorder?

British Pioneers in Cancer Biology

Cancer Prognosis

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

CDK9 and Cancer

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Acidosis and Tumor Progression

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Pediatric Cancer

What is Merkel Cell Carcinoma?

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer Research

What Role do Biobanks Play in Cancer Research?

TARDIS: The Improved Method of Detecting Breast Cancer

Targeted Cancer Therapies

Myc Mutations and Cancer

Latest Cancer News and Research

Vaping or smoking found to reduce fitness in young people by 15%

http://click.agilitypr.delivery/ls/click?upn=u001.Tc7zVj18oed-2F4uPsROK8aAbfeBahNf4wJ8s-2B8sMHqZWlEMd4h1Sy-2BVY7efcyzp0SSp9ahYr1EYI961foGMI00g-3D-3DIFTS_pIbxPfpDI69aAybPrpOfg0m1W6EzqVs-2FmHUNkXZ2e6j0vHkwSAXmnZeE-2FQommlLLwzsQqlRVkMJiMrz424piBBRT-2Fl4JRA42irLftTP4-2BNo-2Bd3OoK5qZ1km0Y7zpf3Y6U1R4brw1FQfk2dP9SvR-2B5Q9WS-2B5kYgdBFGO6Cp64KoEGS08qwKU3-2BLebJZNhRNQhJ0vijfSASstkVMufip2Cj0PwGsD6flTj2e2H-2FZmz1WGGYjzKXlHdt27JIG-2FDNO5Tdh6hvJDVnz-2BD0MeygRgiMELCa45-2FO0LwmdimCKMxJjFlTTl-2BjQEM2Zcmuf8O0CaVbbm5qkG8yvhOX0EQYOSE5UDE8Dqd5OMVgvbA9ZRZqD5q32JB0ZEMWvAhqDWWTzD2BbRc89xCxmkglF5A-2FwQm1uaUZsLnYcnJkAfB9sRgyY6Hskqo9dReJC7Q2gvKnR4J2sRLqipxirF7poCracd5zE9x3FQNBKvEoBOaim6TZyA-3D

14 Jul 2026

Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site

Evonik is making a significant investment to strengthen manufacturing capabilities at its Lafayette (Tippecanoe), Indiana facility.

From Evonik 14 Jul 2026

Vaping reduces fitness and blood vessel function in young adults

Young people who vape or smoke cigarettes have reduced blood vessel functionality, breathing efficiency and exercise capacity compared to those who have never smoked or vaped, according to a study published today in ERJ Open Research.

13 Jul 2026

Combination treatment strategy uses cells' waste removal functions to dismantle multiple myeloma

New research out of VCU Massey Comprehensive Cancer Center provides promising evidence for an innovative combination treatment strategy that uses cells' waste removal functions to effectively dismantle multiple myeloma.

13 Jul 2026

Structural study identifies unexpected cancer-regulating functions of MLL4 protein

The epigenetic modifier MLL4 has an unassuming name-the 4, for instance, indicates it's just one in a family of such modifiers.

13 Jul 2026

Researchers uncover hidden mechanism behind cancer-linked SPOP mutations

Mutations to the protein SPOP are widespread in cancer, yet many remain poorly understood. To address this gap, St. Jude Children's Research Hospital scientists obtained structures of SPOP in both the presence and absence of these mutations.

13 Jul 2026

High physician knowledge scores linked to lower healthcare costs

Patients whose physicians scored higher in the first year of the American Board of Internal Medicine's (ABIM) Internal Medicine Longitudinal Knowledge Assessment (LKA) were significantly less likely to receive low-value healthcare services, which cumulatively cost the U.S. healthcare system an estimated $100 billion each year.

13 Jul 2026

Dysregulation of immune regulator NF-κB drives major human diseases

NF‑κB controls genes involved in inflammation, immunity, cell survival, and proliferation. Triggered by cytokines (TNF‑α, IL‑1β), microbial products, or cellular stress, it translocates to the nucleus and induces pro‑inflammatory mediators.

13 Jul 2026

New approach accurately predicts lung cancer mutations

Scientists have developed a new method for accurately predicting gene changes that cause lung cancer, without the need for slower, more expensive lab techniques.

13 Jul 2026

New therapy targets Hippo pathway to fight treatment-resistant acute myeloid leukemia

Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy remained effective in treatment-resistant acute myeloid leukemia (AML) through activating the Hippo pathway, a tumor-suppressing pathway linked to cancer growth and drug resistance.

13 Jul 2026

Weekly electronic symptom check-ins improve advanced cancer care

New results from an Alliance Foundation Trials (AFT) study reveal that a simple weekly electronic symptom check-in with care team, significantly improves the quality of life for individuals undergoing treatment for advanced cancer.

13 Jul 2026

Study reveals substantial rise in Latin American dementia rates

A new study led by researchers at Washington University School of Medicine in St. Louis and Newcastle University in the U.K. finds that the share of adults living with dementia rose substantially across several Latin American and Caribbean sites over the past two decades.

13 Jul 2026

New report outlines practical strategies to improve hematological care for women

A new report in The Lancet Haematology, led by Cleveland Clinic hematologist Bethany Samuelson Bannow, M.D., outlines practical strategies to improve diagnosis, care and outcomes globally for women and girls with hematological conditions, such as bleeding disorders, heavy menstrual bleeding, postpartum hemorrhage, thrombosis and maternal hematologic complications.

13 Jul 2026

Global consortium releases AI toolbox to unlock new Alzheimer's treatments

The Consortium for Biomedical Research and Artificial Intelligence in Neurodegeneration (C-BRAIN), a global collaboration of academic researchers, pharmaceutical companies, and philanthropic organizations of which Washington University School of Medicine in St. Louis is a founding member, today launched three open-source AI tools to accelerate research aimed at developing new treatments for Alzheimer's disease and other neurodegenerative diseases.

13 Jul 2026

EGFR inhibitors may overcome chemotherapy resistance in glioblastoma treatment

Treating glioblastoma with a class of drugs known as EGFR inhibitors made this cancer more sensitive to chemotherapy, suggests a study in preclinical models co-led by researchers at UT Southwestern Medical Center and the University of Alabama at Birmingham.

12 Jul 2026

Insurance-supported integrative oncology symptom management program benefits cancer patients

A new study from University Hospitals Connor Whole Health reports that an insurance-supported integrative oncology program resulted in clinically meaningful improvements in cancer-related symptoms like pain, stress, anxiety, depression, nausea, and fatigue.

11 Jul 2026

New viral library helps scientists study thousands of proteins

To prevent viruses from sickening or killing us - whether it's an individual case of hepatitis B or a COVID pandemic - it's crucial to understand how the proteins they make initiate changes in our bodies that allow them to flourish.

11 Jul 2026

Rural radiation oncology clinic closures threaten cancer patient care

A new study led by researchers at the Icahn School of Medicine at Mount Sinai found that although the overall number of radiation oncology clinics in the United States has appeared stable in recent years, many individual treatment centers have quietly closed while others have opened.

11 Jul 2026

Machine learning redefines precision cancer therapy using smart radiopharmaceuticals

JMIR Publications released a feature News and Perspectives story on technological advances in oncology.

11 Jul 2026

New generation approaches revive BET protein inhibitors in solid tumors

BET proteins, especially BRD4, drive oncogenic transcription in solid tumours. First‑generation inhibitors (JQ1, molibresib, birabresib) showed preclinical promise but failed clinically due to modest efficacy, dose‑limiting thrombocytopenia, and resistance (isoform switching, compensatory PI3K/AKT/WNT signalling).

11 Jul 2026